These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 30354757)

  • 1. Prevalence of Hypertension and Cardiovascular Risk According to Blood Pressure Thresholds Used for Diagnosis.
    Lamprea-Montealegre JA; Zelnick LR; Hall YN; Bansal N; de Boer IH
    Hypertension; 2018 Sep; 72(3):602-609. PubMed ID: 30354757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating the Association of the 2017 and 2014 Hypertension Guidelines With Cardiovascular Events and Deaths in US Adults: An Analysis of National Data.
    Bundy JD; Mills KT; Chen J; Li C; Greenland P; He J
    JAMA Cardiol; 2018 Jul; 3(7):572-581. PubMed ID: 29800138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Cardiovascular Disease Events Prevented with Adoption of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline.
    Bress AP; Colantonio LD; Cooper RS; Kramer H; Booth JN; Odden MC; Bibbins-Domingo K; Shimbo D; Whelton PK; Levitan EB; Howard G; Bellows BK; Kleindorfer D; Safford MM; Muntner P; Moran AE
    Circulation; 2019 Jan; 139(1):24-36. PubMed ID: 30586736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of the Blood Pressure Categories, as Defined by the ACC/AHA 2017 Blood Pressure Guidelines, and the Risk of  Development of Cardiovascular Disease in Low-Risk Young  Adults: Insights From a Retrospective Cohort of Young Adults.
    Kim S; Chang Y; Kang J; Cho A; Cho J; Hong YS; Zhao D; Ahn J; Shin H; Guallar E; Ryu S; Sung KC
    J Am Heart Assoc; 2019 Jun; 8(11):e011946. PubMed ID: 31140347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generalizability of SPRINT Results to the U.S. Adult Population.
    Bress AP; Tanner RM; Hess R; Colantonio LD; Shimbo D; Muntner P
    J Am Coll Cardiol; 2016 Feb; 67(5):463-72. PubMed ID: 26562046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of new hypertension guidelines in the United States.
    Bertoia ML; Waring ME; Gupta PS; Roberts MB; Eaton CB
    Hypertension; 2011 Sep; 58(3):361-6. PubMed ID: 21768528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential impacts of the 2017 American College of Cardiology/American Heart Association high blood pressure guideline on Chinese adults and how to address them.
    Jiao Y; Sun Z; Xie Y; Zheng J; Li Z; Guo X; Dai Y; Zheng L; Sun Y
    BMC Cardiovasc Disord; 2020 May; 20(1):237. PubMed ID: 32429909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examination Survey).
    Bress AP; Kramer H; Khatib R; Beddhu S; Cheung AK; Hess R; Bansal VK; Cao G; Yee J; Moran AE; Durazo-Arvizu R; Muntner P; Cooper RS
    Circulation; 2017 Apr; 135(17):1617-1628. PubMed ID: 28193605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistant hypertension and cardiovascular disease mortality in the US: results from the National Health and Nutrition Examination Survey (NHANES).
    Kaczmarski KR; Sozio SM; Chen J; Sang Y; Shafi T
    BMC Nephrol; 2019 Apr; 20(1):138. PubMed ID: 31023262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular Health and Transition From Controlled Blood Pressure to Apparent Treatment Resistant Hypertension: The Jackson Heart Study and the REGARDS Study.
    Akinyelure OP; Sakhuja S; Colvin CL; Clark D; Jaeger BC; Hardy ST; Howard G; Cohen LP; Irvin MR; Tanner R; Carey RM; Muntner P
    Hypertension; 2020 Dec; 76(6):1953-1961. PubMed ID: 33131312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A data-zone scoring system to assess the generalizability of clinical trial results to individual patients.
    Laffin LJ; Besser SA; Alenghat FJ
    Eur J Prev Cardiol; 2019 Apr; 26(6):569-575. PubMed ID: 30477321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline Blood Pressure, the 2017 ACC/AHA High Blood Pressure Guidelines, and Long-Term Cardiovascular Risk in SPRINT.
    Vaduganathan M; Pareek M; Qamar A; Pandey A; Olsen MH; Bhatt DL
    Am J Med; 2018 Aug; 131(8):956-960. PubMed ID: 29421687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ambulatory Blood Pressure Monitoring (ABPM) as the reference standard for diagnosis of hypertension and assessment of vascular risk in adults.
    Hermida RC; Smolensky MH; Ayala DE; Portaluppi F
    Chronobiol Int; 2015; 32(10):1329-42. PubMed ID: 26587588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Isolated Diastolic Hypertension Based on the Cutoff Value in the 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines With Subsequent Cardiovascular Events in the General Population.
    Kaneko H; Itoh H; Yotsumoto H; Kiriyama H; Kamon T; Fujiu K; Morita K; Michihata N; Jo T; Takeda N; Morita H; Yasunaga H; Komuro I
    J Am Heart Assoc; 2020 Oct; 9(19):e017963. PubMed ID: 32993440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of Populations Excluded From Clinical Trials Supporting Intensive Blood Pressure Control Guidelines.
    Anderson TS; Odden MC; Penko J; Kazi DS; Bellows BK; Bibbins-Domingo K
    J Am Heart Assoc; 2021 Apr; 10(7):e019707. PubMed ID: 33754796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of Child and Adult Elevated Blood Pressure on Adult Arterial Stiffness: The Cardiovascular Risk in Young Finns Study.
    Aatola H; Koivistoinen T; Tuominen H; Juonala M; Lehtimäki T; Viikari JSA; Raitakari OT; Kähönen M; Hutri-Kähönen N
    Hypertension; 2017 Sep; 70(3):531-536. PubMed ID: 28674036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impacts of the New 2017 ACC/AHA Hypertension Guideline on the Prevalence of Brachial Hypertension and Its Concordance with Central Hypertension.
    Chuang SY; Chang HY; Cheng HM; Pan WH; Chen CH
    Am J Hypertens; 2019 Mar; 32(4):409-417. PubMed ID: 30657845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of Hypertension Management Strategies in SPRINT-Eligible US Adults: A Simulation Study.
    Zhang F; Bryant KB; Moran AE; Zhang Y; Cohen JB; Bress AP; Sheppard JP; King JB; Derington CG; Weintraub WS; Kronish IM; Shea S; Bellows BK
    J Am Heart Assoc; 2024 Jan; 13(2):e032370. PubMed ID: 38214272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proportion and Characteristics of US Adults Who May Be Eligible From Additional Blood Pressure Lowering Based on Absolute Risk.
    Odutayo AA; Tennankore KK; Emdin CA
    Am J Hypertens; 2017 Mar; 30(3):232-235. PubMed ID: 27838623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalizing the Intensity of Blood Pressure Control: Modeling the Heterogeneity of Risks and Benefits From SPRINT (Systolic Blood Pressure Intervention Trial).
    Patel KK; Arnold SV; Chan PS; Tang Y; Pokharel Y; Jones PG; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2017 Apr; 10(4):. PubMed ID: 28373269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.